Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director/PDMR Shareholding

30th Jun 2011 16:53

RNS Number : 5241J
GW Pharmaceuticals PLC
30 June 2011
 



 

GW Pharmaceuticals PLC

 

("GW Pharmaceuticals" or the "Company")

 

NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS

 

Porton Down, UK, 30 June 2011: GW Pharmaceuticals (AIM: GWP) hereby provides notification that the Company has today been notified of the following share transactions entered into by David Kirk, a Director of the Company.

 

On 29 June 2011, David Kirk exercised share options over 900,000 ordinary shares of 0.1 pence each with an exercise price of 104.5 pence per share. These options were 10 year options, granted in September 2001, which would have expired if not exercised before 10 September 2011. The resulting new ordinary shares, representing 0.68% of the Company's issued share capital, were immediately sold at a price of 118 pence per share.

 

Following these transactions, David Kirk continues to hold a beneficial interest in 59,500 GW Pharmaceuticals plc 0.1 pence ordinary shares, representing 0.04% of the Company's issued share capital.

 

The total number of shares outstanding in the Company is 132,935,692 ordinary shares of 0.1 pence each.

 

- Ends -

 

Enquiries:

 

GW Pharmaceuticals PLC

Adam George, Company Secretary

Tel: +44 (0)1980 557 000

 

Peel Hunt LLP (Nominated Adviser)

James Steel/Vijay Barathan

 

Tel: +44 (0)207 418 8900

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFEERFIIVIL

Related Shares:

GWP.L
FTSE 100 Latest
Value8,885.61
Change21.26